Verition Fund Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
32,820
-40,989
| -56% | -$378K | ﹤0.01% | 2476 |
|
|
2025
Q1 | $633K | Buy |
73,809
+37,142
| +101% | +$319K | ﹤0.01% | 1849 |
|
|
2024
Q4 | $394K | Buy |
+36,667
| New | +$394K | ﹤0.01% | 2009 |
|
|
2016
Q2 | – | Sell |
-16,478
| Closed | -$81K | – | 785 |
|
|
2016
Q1 | $81K | Buy |
+16,478
| New | +$81K | 0.01% | 614 |
|